{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T05:04:30Z","timestamp":1789362270930,"version":"build-2803163510"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Background\/Objectives<\/jats:title>\n                    <jats:p>Probiotics have attracted much attention due to their ability to modulate nutrient metabolism or immunomodulatory. This study aims to evaluate the efficacy of probiotic supplementation in the treatment of metabolic syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed, Web of Science, Embase, and Cochrane Library were systematically searched searched for eligible clinical trials published from database inception to July 2024. STATA\/SE 14.0 software was used for statistical analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 12 clinical trials with 633 patients diagnosed with metabolic syndrome were included. The intervention group received probiotic supplementations. The control group received placebo. HDL level was significantly higher with probiotic supplementation than that in the placebo group (WMD = 1.63 mg\/dL, 95%CI: [\u22120.10, 3.36],\n                      <jats:italic>p<\/jats:italic>\n                      = 0.065; I\n                      <jats:sup>2<\/jats:sup>\n                      = 89.7%,\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001). LDL level was significantly lower with probiotic supplementation than that in the placebo group (WMD = \u22120.59 mg\/dL, 95%CI: [\u22121.17, \u22120.02],\n                      <jats:italic>p<\/jats:italic>\n                      = 0.044; I\n                      <jats:sup>2<\/jats:sup>\n                      = 33.4%,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.123). For age \u226450 years, probiotics supplement inhibited the serum triglyceride levels (WMD = \u221210.75 mg\/dL, 95%CI: [\u221222.17, 0.67],\n                      <jats:italic>p<\/jats:italic>\n                      = 0.065; I\n                      <jats:sup>2<\/jats:sup>\n                      = 77.8%,\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001). Significant difference was observed in glucose (WMD = \u22120.58 mg\/dL, 95%CI: [\u22121.15, \u22120.02],\n                      <jats:italic>p<\/jats:italic>\n                      = 0.043; I\n                      <jats:sup>2<\/jats:sup>\n                      = 0.0%,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.966), whereas no significant difference was observed in total cholesterol between two groups (WMD = 1.80 mg\/dL, 95%CI: [\u22125.37, 8.98],\n                      <jats:italic>p<\/jats:italic>\n                      = 0.622; I\n                      <jats:sup>2<\/jats:sup>\n                      = 87.4%,\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study indicates that probiotic supplementation shows potential therapeutic benefit in metabolic syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero\/<\/jats:ext-link>\n                      , identifier CRD42025628477.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1888320","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T04:34:17Z","timestamp":1789360457000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The clinical effects of probiotic supplementations on metabolic syndrome: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Min","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Ningbo No.6 Hospital","place":["Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ningbo No.6 Hospital","place":["Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ningbo No.6 Hospital","place":["Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/ijms23020786","article-title":"Metabolic syndrome: updates on pathophysiology and management in 2021.","volume":"23","author":"Fahed","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.5717\/jenb.2014.18.4.361","article-title":"Roles of physical activity and cardiorespiratory fitness on sex difference in insulin resistance in late elementary years.","volume":"18","author":"Hong","year":"2014","journal-title":"J Exerc Nutrition Biochem"},{"key":"B3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","article-title":"The global epidemic of the metabolic syndrome.","volume":"20","author":"Saklayen","year":"2018","journal-title":"Curr Hypertens Rep"},{"key":"B4","doi-asserted-by":"publisher","first-page":"E24","DOI":"10.5888\/pcd14.160287","article-title":"Metabolic syndrome prevalence by race\/ethnicity and sex in the United States, national health and nutrition examination survey, 1988-2012.","volume":"14","author":"Moore","year":"2017","journal-title":"Prev Chronic Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"621","DOI":"10.6133\/apjcn.201909_28(3).0023","article-title":"Prevalence of metabolic syndrome and individual metabolic abnormalities in China, 2002-2012.","volume":"28","author":"He","year":"2019","journal-title":"Asia Pac J Clin Nutr"},{"key":"B6","doi-asserted-by":"publisher","first-page":"74290","DOI":"10.1007\/s11356-023-27459-3","article-title":"Association between serum aldehyde concentrations and metabolic syndrome in adults.","volume":"30","author":"Ba","year":"2023","journal-title":"Environ Sci Pollut Res Int"},{"key":"B7","doi-asserted-by":"publisher","first-page":"276","DOI":"10.2174\/1871527321666220329140804","article-title":"Role of brain-gut-microbiota axis in depression: emerging therapeutic avenues.","volume":"22","author":"Bhatt","year":"2023","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"B8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","article-title":"Gut microbiota in human metabolic health and disease.","volume":"19","author":"Fan","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3390\/microorganisms8040527","article-title":"Role of gut microbiota in neuroendocrine regulation of carbohydrate and lipid metabolism via the microbiota-gut-brain-liver axis.","volume":"8","author":"Wang","year":"2020","journal-title":"Microorganisms"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e13409","DOI":"10.1111\/obr.13409","article-title":"Human microbiome and metabolic health: an overview of systematic reviews.","volume":"23","author":"Michels","year":"2022","journal-title":"Obes Rev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3390\/nu12010079","article-title":"The gut microbiota affects host pathophysiology as an endocrine organ: a focus on cardiovascular disease.","volume":"12","author":"Busnelli","year":"2019","journal-title":"Nutrients"},{"key":"B12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bpg.2015.12.001","article-title":"Probiotics: definition, scope and mechanisms of action.","volume":"30","author":"Reid","year":"2016","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12967-022-03296-9","article-title":"Microbiota medicine: towards clinical revolution.","volume":"20","author":"Gebrayel","year":"2022","journal-title":"J Transl Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"11872","DOI":"10.3390\/ijms222111872","article-title":"Early-life origins of metabolic syndrome: mechanisms and preventive aspects.","volume":"22","author":"Hsu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3390\/ijms17060928","article-title":"Effects of probiotics and synbiotics on obesity, insulin resistance syndrome, type 2 diabetes and non-alcoholic fatty liver disease: a review of human clinical trials.","volume":"17","author":"S\u00e1ez-Lara","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1159\/000499028","article-title":"Probiotic foods and supplements interventions for metabolic syndromes: a systematic review and meta-analysis of recent clinical trials.","volume":"74","author":"Dong","year":"2019","journal-title":"Ann Nutr Metab"},{"key":"B17","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.nut.2013.12.004","article-title":"Beneficial effects of lactobacillus plantarum on glycemia and homocysteine levels in postmenopausal women with metabolic syndrome.","volume":"30","author":"Barreto","year":"2014","journal-title":"Nutrition"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/ejcn.2012.103","article-title":"The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: an open label, randomized pilot study.","volume":"66","author":"Leber","year":"2012","journal-title":"Eur J Clin Nutr"},{"key":"B19","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.pedhc.2021.04.011","article-title":"PRISMA 2020: an update.","volume":"35","author":"Swartz","year":"2021","journal-title":"J Pediatr Health Care"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1194\/jlr.R120000922","article-title":"Aging and plasma triglyceride metabolism.","volume":"61","author":"Spitler","year":"2020","journal-title":"J Lipid Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"ED000142","DOI":"10.1002\/14651858.ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the cochrane handbook for systematic reviews of interventions.","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias.","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics."},{"key":"B23","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.nut.2015.11.001","article-title":"Beneficial effects of bifidobacterium lactis on lipid profile and cytokines in patients with metabolic syndrome: a randomized trial. Effects of probiotics on metabolic syndrome.","volume":"32","author":"Bernini","year":"2016","journal-title":"Nutrition"},{"key":"B24","doi-asserted-by":"publisher","first-page":"917043","DOI":"10.3389\/fnut.2022.917043","article-title":"Probiotics interact with lipids metabolism and affect gut health.","volume":"9","author":"Wu","year":"2022","journal-title":"Front Nutr"},{"key":"B25","doi-asserted-by":"publisher","first-page":"293","DOI":"10.18632\/aging.101775","article-title":"HDL dysfunction, function, and heart failure.","volume":"11","author":"Mishra","year":"2019","journal-title":"Aging"},{"key":"B26","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s12602-023-10068-4","article-title":"Probiotics and prebiotics in subclinical hypothyroidism of pregnancy with small intestinal bacterial overgrowth.","volume":"16","author":"Ouyang","year":"2024","journal-title":"Probiotics Antimicrob Proteins"},{"key":"B27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.atherosclerosis.2020.02.003","article-title":"Oxidized low-density lipoprotein (LDL) and LDL cholesterol are associated with outcomes of minor stroke and TIA.","volume":"297","author":"Wang","year":"2020","journal-title":"Atherosclerosis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.tcm.2018.05.010","article-title":"Oxidized LDL and anti-oxidized LDL antibodies in atherosclerosis - novel insights and future directions in diagnosis and therapy<sup\/>.","volume":"29","author":"Hartley","year":"2019","journal-title":"Trends Cardiovasc Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e0132121","DOI":"10.1371\/journal.pone.0132121","article-title":"Effect of probiotics on glycemic control: a systematic review and meta-analysis of.","volume":"10","author":"Ruan","year":"2015","journal-title":"Randomized, Controlled Trials."},{"key":"B30","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/nu12010124","article-title":"Effects of probiotics on metabolic syndrome: a systematic review of randomized clinical trials.","volume":"12","author":"Tenorio-Jim\u00e9nez","year":"2020","journal-title":"Nutrients"},{"key":"B31","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00394-020-02271-8","article-title":"Impact of a short-term synbiotic supplementation on metabolic syndrome and systemic inflammation in elderly patients: a randomized placebo-controlled clinical trial.","volume":"60","author":"Cicero","year":"2021","journal-title":"Eur J Nutr"},{"key":"B32","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/bmjmilitary-2020-001459","article-title":"Effects of synbiotic supplementation on the components of metabolic syndrome in military personnel: a double-blind randomised controlled trial.","volume":"168","author":"Parastouei","year":"2022","journal-title":"BMJ Mil Health"},{"key":"B33","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1017\/S0007114514000919","article-title":"Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study.","volume":"112","author":"Eslamparast","year":"2014","journal-title":"Br J Nutr"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2967977","DOI":"10.1155\/2022\/2967977","article-title":"Efficacy of the synbiotic supplementation on the metabolic factors in patients with metabolic syndrome: a randomized, triple-blind, placebo-controlled trial.","volume":"2022","author":"Rahimi","year":"2022","journal-title":"Int J Clin Pract"},{"key":"B35","doi-asserted-by":"publisher","first-page":"104577","DOI":"10.1016\/j.idairyj.2019.104577","article-title":"Evaluation of the effects of probiotic yoghurt on inflammation and cardiometabolic risk factors in subjects with metabolic syndrome: a randomised controlled trial.","volume":"101","author":"Rezazadeh","year":"2020","journal-title":"Int Dairy J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jff.2017.12.041","article-title":"Effect of the consumption of a synbiotic diet mousse containing lactobacillus acidophilus La-5 by individuals with metabolic syndrome: a randomized controlled trial.","volume":"41","author":"Xavier-Santos","year":"2018","journal-title":"J Funct Foods."},{"key":"B37","doi-asserted-by":"publisher","first-page":"100266","DOI":"10.1016\/j.phanu.2021.100266","article-title":"Kefir improves blood parameters and reduces cardiovascular risks in patients with metabolic syndrome.","volume":"16","author":"Ghizi","year":"2021","journal-title":"PharmaNutrition."},{"key":"B38","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.numecd.2018.03.001","article-title":"The effect of daily fortified yogurt consumption on weight loss in adults with metabolic syndrome: a 10-week randomized controlled trial.","volume":"28","author":"Mohammadi-Sartang","year":"2018","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/1475-2891-12-138","article-title":"Hypocaloric diet supplemented with probiotic cheese improves body mass index and blood pressure indices of obese hypertensive patients\u2013a randomized double-blind placebo-controlled pilot study.","volume":"12","author":"Sharafedtinov","year":"2013","journal-title":"Nutr J"},{"key":"B40","doi-asserted-by":"publisher","first-page":"104076","DOI":"10.1016\/j.fbio.2024.104076","article-title":"A randomised double-blind placebo-controlled trial of a probiotic combination for manipulating the gut microbiota and managing metabolic syndrome.","volume":"59","author":"Xiao","year":"2024","journal-title":"Food Biosci."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1888320\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T04:34:28Z","timestamp":1789360468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1888320\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":40,"alternative-id":["10.3389\/fnut.2026.1888320"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1888320","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"article-number":"1888320"}}